The Cannabinoid Receptor Agonist WIN 55,212-2 Reduces D2, but Not D1, Dopamine Receptor-Mediated Alleviation of Akinesia in the Reserpine-Treated Rat Model of Parkinson's Disease

1997 ◽  
Vol 148 (1) ◽  
pp. 265-270 ◽  
Author(s):  
Y.P. Maneuf ◽  
A.R. Crossman ◽  
J.M. Brotchie
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Receptor ◽  
Rat Model ◽  
Receptor Agonist ◽  
Cannabinoid Receptor ◽  
D1 Dopamine Receptor

Selective D-1 dopamine receptor agonist treatment of parkinson's disease

1987 ◽  
Vol 68 (1-2) ◽  
pp. 41-50 ◽  
Author(s):  
A. Braun ◽  
G. Fabbrini ◽  
M. M. Mouradian ◽  
C. Serrati ◽  
P. Barone ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Receptor ◽  
Receptor Agonist ◽  
Dopamine Receptor Agonist

scholarly journals Othello Syndrome Secondary to Ropinirole: A Case Study

2012 ◽  
Vol 2012 ◽  
pp. 1-2
Author(s):  
Kakali Pal ◽  
Abigail Smith ◽  
Joseph Hayes ◽  
Apu Chakraborty
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Case Report ◽  
Dose Reduction ◽  
Dopamine Receptor ◽  
Receptor Agonist ◽  
Dopamine Receptor Agonist ◽  
Psychiatric History ◽  
Delusional Jealousy

This case report describes a forty-two-year-old man with no previous psychiatric history who developed delusional jealousy (Othello Syndrome) associated with ropinirole treatment. Ropinirole is a commonly used dopamine receptor agonist, which was being used to treat his Parkinson’s disease, and his delusional symptoms resolved entirely with ropinirole dose reduction.

Sign in / Sign up

Export Citation Format

Share Document